During the past decade, University of Kansas Hospital-Westwood Cancer Center conducted 252 clinical trials. In the 10-year time frame, 252 clinical trials started and 64 clinical trials were completed, i.e. on average, 25.4% percent of trials that started reached the finish line to date. In the past 5 years, 126 clinical trials started and 45 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Hospital-Westwood Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "University of Kansas Medical Center" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored and "NRG Oncology" with 19 trials sponsored. Other sponsors include 126 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Hospital-Westwood Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Hospital-Westwood Cancer Center" are "Multiple Myeloma" (15 trials), "Breast Cancer" (10 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Prostate Adenocarcinoma" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "University of Kansas Hospital-Westwood Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Kansas Hospital-Westwood Cancer Center" are "Drug" (226 trials), "Biological" (98 trials), "Other" (88 trials), "Procedure" (70 trials) and "Radiation" (43 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (39 trials), "Biospecimen Collection" (38 trials), "Computed Tomography" (34 trials), "Laboratory Biomarker Analysis" (33 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Hospital-Westwood Cancer Center" are 257 trials for "All" genders, 26 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Hospital-Westwood Cancer Center". undefined are not yet recruiting, 104 are recruiting, 109 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in University of Kansas Hospital-Westwood Cancer Center, 10 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Hospital-Westwood Cancer Center, 53 "Phase 1" clinical trials were conducted, 164 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

University of Kansas Hospital-Westwood Cancer Center has several departments that took part in Clinical trials: "University of Kansas Medical Center" - 4 trials, "The University of Kansas Cancer Center - Investigational Drug Services" - 3 trials, "Lipid, Atherosclerosis & Metabolic Clinic" - 2 trials, "Cray Diabetes Education Center" - 2 trials